{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:32:01Z","timestamp":1793640721424,"version":"4.5.1"},"reference-count":48,"publisher":null,"issue":"11","license":[{"start":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T00:00:00Z","timestamp":1732924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/lib.ossn.ru\/jour\/about\/editorialPolicies#openAccessPolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kardiologiia"],"abstract":"<jats:p>\n                    <jats:italic>Aim<\/jats:italic>\n                    \u00a0\u00a0\u00a0\u00a0\u00a0 To evaluate the role of iron deficiency (ID) identified by various criteria, anemia, and the combination of ID and anemia in determining the severity of the clinical course of chronic heart failure (CHF) in a retrospective analysis of data from 498 patients who participated in the ID-CHF-RF Russian multicenter program.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Material and methods<\/jats:italic>\n                    \u00a0 ID was diagnosed by the following three criteria established by the European Society of Cardiology (ESC) and the Russian Society of Cardiology (RSC): 1) ferritin concentration &lt;100 \u03bcg\/l or ferritin concentration 100-299 \u03bcg\/l in combination with a decreased transferrin saturation (TS) &lt;20%; 2) ID criteria that showed a high sensitivity and specificity when compared with bone marrow morphology (BMM): TS \u226419.8% or serum iron (SI) \u226413 \u03bcmol\/l; and 3) a composite index including a ferritin concentration &lt;100 \u03bcg\/l in combination with TS &lt;20% and SI \u226413 \u03bcmol\/l. The presence of anemia was defined as a hemoglobin concentration of less than 12.0 g\/dl in women and less than 13.0 g\/dl in men according to the criteria of the World Health Organization.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Results<\/jats:italic>\n                    Concomitant anemia was detected in 40.3% of patients with CHF; in 85.1% of cases, anemia was combined with the SI concentration below normal. CHF patients with concomitant anemia were significantly older and had low levels of not only red blood cells and hemoglobin but also all parameters of iron metabolism, i.e., SI, ferritin concentration, and TS. The mean deviation of the red blood cell size, that characterizes the degree of anisocytosis, was significantly increased in patients with anemia, especially with a low SI. These patients had a higher CHF functional class, elevated levels of N-terminal fragment of pro-brain natriuretic peptide (NT-proBNP) and walked a shorter distance in the 6-minute walk test, which reflects significantly more severe manifestations of CHF with concomitant anemia, particularly in combination with a low SI. The incidence of ID was 83.1% (including 23.3% in combination with anemia) according to the ESC\/RSC criteria; 74.5% (including 43.3% with anemia) according to the BMM criteria; and 51.6% (including 51.7% with anemia) according to the composite index, which seems to be stricter compared to the first two criteria. Regardless of the assessment method (by total weighted average data), in ID combined with anemia, not only the hemoglobin concentration was significantly reduced but all three analyzed parameters of iron metabolism were also significantly reduced (SI 9.0 \u03bcmol\/l\n                    <jats:italic>vs<\/jats:italic>\n                    . 10.4 \u03bcmol\/l; ferritin 41 \u03bcg\/l\n                    <jats:italic>vs.<\/jats:italic>\n                    59 \u03bcg\/l; TS 8.5%\n                    <jats:italic>vs.<\/jats:italic>\n                    12.9%) compared to ID without anemia, respectively. The CHF severity and the NT-proBNP concentration were also maximum for the combination of ID and anemia, in contrast to ID without anemia, regardless of the ID criterion used. A more accurate comparison of the methods for determining ID in CHF in the context of their prognostic value will be obtained by analyzing the data of a two-year follow-up of patients in this study, which will be the subject of the next article.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Conclusion<\/jats:italic>\n                    \u00a0\u00a0\u00a0\u00a0\u00a0 This analysis suggests that the presence of concomitant ID without anemia or anemia without ID moderately affects the severity of clinical manifestations of CHF and may be rather markers than factors determining the course of the disease, and in this case, does not require special correction with iron medications. And only ID anemia (a combination of ID with anemia) in patients with CHF can be considered a condition requiring special correction (for example, with intravenous medication) in addition to optimal therapy for CHF. This conclusion does not change depending on the used criteria for ID and requires verification in new RCTs.\n                  <\/jats:p>","DOI":"10.18087\/cardio.2024.11.n2786","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T11:36:35Z","timestamp":1733398595000},"page":"62-75","source":"Crossref","is-referenced-by-count":5,"title":["Relationship of Iron Deficiency, Anemia and Combination of Iron Deficiency With Anemia With Severity of Manifestations of Chronic Heart Failure. Additional Analysis of the Study \u201cPrevalence of Iron Deficiency in Patients With Chronic Heart Failure in the Russian Federation (J-CHF-RF)\u201d"],"prefix":"10.68900","volume":"64","author":[{"given":"V. Yu.","family":"Mareev","sequence":"first","affiliation":[{"name":"Medical Research and Educational Institute of the Lomonosov Moscow State University, Moscow"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zh. D.","family":"Kobalava","sequence":"additional","affiliation":[{"name":"Moiseev Department of Internal Diseases with a Course of Cardiology and Functional Diagnostics, Medical Institute, Patrice Lumumba Peoples\u2019 Friendship University of Russia, Moscow;\r\nVinogradov Municipal Clinical Hospital, Moscow"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu. V.","family":"Mareev","sequence":"additional","affiliation":[{"name":"Robertson Center for Biostatistics, Glasgow University, Glasgow"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu. L.","family":"Begrambekova","sequence":"additional","affiliation":[{"name":"Medical Research and Educational Institute of the Lomonosov Moscow State University, Moscow"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. V.","family":"Karapetyan","sequence":"additional","affiliation":[{"name":"Moiseev Department of Internal Diseases with a Course of Cardiology and Functional Diagnostics, Medical Institute, Patrice Lumumba Peoples\u2019 Friendship University of Russia, Moscow;\r\nVinogradov Municipal Clinical Hospital, Moscow"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. A.","family":"Galochkin","sequence":"additional","affiliation":[{"name":"Moiseev Department of Internal Diseases with a Course of Cardiology and Functional Diagnostics, Medical Institute, Patrice Lumumba Peoples\u2019 Friendship University of Russia, Moscow;\r\nVinogradov Municipal Clinical Hospital, Moscow"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. R.","family":"Kazakhmedov","sequence":"additional","affiliation":[{"name":"Moiseev Department of Internal Diseases with a Course of Cardiology and Functional Diagnostics, Medical Institute, Patrice Lumumba Peoples\u2019 Friendship University of Russia, Moscow;\r\nVinogradov Municipal Clinical Hospital, Moscow"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. A.","family":"Lapshin","sequence":"additional","affiliation":[{"name":"Moiseev Department of Internal Diseases with a Course of Cardiology and Functional Diagnostics, Medical Institute, Patrice Lumumba Peoples\u2019 Friendship University of Russia, Moscow;\r\nVinogradov Municipal Clinical Hospital, Moscow"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. A.","family":"Garganeeva","sequence":"additional","affiliation":[{"name":"Research Institute of Cardiology, Tomsk Research Medical Center of the Russian Academy of Sciences, Tomsk"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. A.","family":"Kuzheleva","sequence":"additional","affiliation":[{"name":"Research Institute of Cardiology, Tomsk Research Medical Center of the Russian Academy of Sciences, Tomsk"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. A.","family":"Efremushkina","sequence":"additional","affiliation":[{"name":"Altai State Medical University, Barnaul;\r\nAltai Territorial Cardiological Dispensary, Barnaul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. V.","family":"Kiseleva","sequence":"additional","affiliation":[{"name":"Altai Territorial Cardiological Dispensary, Barnaul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. L.","family":"Barbarash","sequence":"additional","affiliation":[{"name":"Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. B.","family":"Pecherina","sequence":"additional","affiliation":[{"name":"Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. S.","family":"Galyavich","sequence":"additional","affiliation":[{"name":"Kazan State Medical University, Kazan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z. M.","family":"Galeeva","sequence":"additional","affiliation":[{"name":"Kazan State Medical University, Kazan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. V.","family":"Baleeva","sequence":"additional","affiliation":[{"name":"Kazan State Medical University, Kazan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. A.","family":"Koziolova","sequence":"additional","affiliation":[{"name":"Vagner Perm State Medical University, Perm"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. S.","family":"Veklich","sequence":"additional","affiliation":[{"name":"Vagner Perm State Medical University, Perm"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. V.","family":"Duplyakov","sequence":"additional","affiliation":[{"name":"Research Institute of Cardiology, Samara State Medical University, Samara;\r\nPolyakov Samara Regional Clinical Cardiological Dispensary, Samara"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. N.","family":"Maksimova","sequence":"additional","affiliation":[{"name":"Polyakov Samara Regional Clinical Cardiological Dispensary, Samara"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. S.","family":"Yakushin","sequence":"additional","affiliation":[{"name":"Pavlov Ryazan State Medical University, Ryazan;\r\nRegional Clinical Cardiology Dispensary, Ryazan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. A.","family":"Smirnova","sequence":"additional","affiliation":[{"name":"Regional Clinical Cardiology Dispensary, Ryazan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. V.","family":"Sedykh","sequence":"additional","affiliation":[{"name":"Pavlov Ryazan State Medical University, Ryazan;\r\nRegional Clinical Cardiology Dispensary, Ryazan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. I.","family":"Shaposhnik","sequence":"additional","affiliation":[{"name":"South Ural State Medical University, Chelyabinsk"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. A.","family":"Makarova","sequence":"additional","affiliation":[{"name":"South Ural State Medical University, Chelyabinsk"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. A.","family":"Zemlyanukhina","sequence":"additional","affiliation":[{"name":"Chelyabinsk Municipal Clinical Hospital #1, Chelyabinsk"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. V.","family":"Skibitskiy","sequence":"additional","affiliation":[{"name":"Kuban State Medical University, Krasnodar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. V.","family":"Fendrikova","sequence":"additional","affiliation":[{"name":"Kuban State Medical University, Krasnodar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. V.","family":"Skibitskiy","sequence":"additional","affiliation":[{"name":"Kuban State Medical University, Krasnodar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. A.","family":"Spiropulos","sequence":"additional","affiliation":[{"name":"Clinical Hospital of Emergency Medical Care, Krasnodar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. M.","family":"Seredenina","sequence":"additional","affiliation":[{"name":"Medical Research and Educational Institute of the Lomonosov Moscow State University, Moscow"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya. A.","family":"Orlova","sequence":"additional","affiliation":[{"name":"Medical Research and Educational Institute of the Lomonosov Moscow State University, Moscow"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. A.","family":"Eruslanova","sequence":"additional","affiliation":[{"name":"Russian Gerontological Research and Clinical Center, Pirogov Russian National Research Medical University, Moscow"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu. V.","family":"Kotovskaya","sequence":"additional","affiliation":[{"name":"Russian Gerontological Research and Clinical Center, Pirogov Russian National Research Medical University, Moscow"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. N.","family":"\u0422kacheva","sequence":"additional","affiliation":[{"name":"Russian Gerontological Research and Clinical Center, Pirogov Russian National Research Medical University, Moscow"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Fedin","sequence":"additional","affiliation":[{"name":"Russian Gerontological Research and Clinical Center, Pirogov Russian National Research Medical University, Moscow;\r\nPirogov Russian National Research Medical University, Moscow"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":null,"published-online":{"date-parts":[[2024,11,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Iyngkaran P, Thomas M, Horowitz JD, Komesaroff P, Jelinek M, Hare DL. Common Comorbidities that Alter Heart Failure Prognosis - Shaping New Thinking for Practice. Current Cardiology Reviews. 2021;17(5):e160721187934. DOI: 10.2174\/1573403X16666201113093548","DOI":"10.2174\/1573403X16666201113093548"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Shlyakhto E.V., Belenkov Yu.N., Boytsov S.A., Villevalde S.V., Galyavich A.S., Glezer M.G. et al. Interim analysis of a prospective observational multicenter registry study of patients with chronic heart failure in the Russian Federation \u201cPRIORITET-CHF\u201d: initial characteristics and treatment of the first included patients. Russian Journal of Cardiology. 2023;28(10):93\u2013103. DOI: 10.15829\/1560-4071-2023-5593","DOI":"10.15829\/1560-4071-2023-5593"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation. 2003;107(2):223\u20135. DOI: 10.1161\/01.CIR.0000052622.51963.FC","DOI":"10.1161\/01.CIR.0000052622.51963.FC"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"O\u2019Meara E. Clinical Correlates and Consequences of Anemia in a Broad Spectrum of Patients With Heart Failure: Results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Circulation. 2006;113(7):986\u201394. DOI: 10.1161\/CIRCULATIONAHA.105.582577","DOI":"10.1161\/CIRCULATIONAHA.105.582577"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Swedberg K, Young JB, Anand IS, Cheng S, Desai AS, Diaz R et al. Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure. New England Journal of Medicine. 2013;368(13):1210\u20139. DOI: 10.1056\/NEJMoa1214865","DOI":"10.1056\/NEJMoa1214865"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Kao DP, Kreso E, Fonarow GC, Krantz MJ. Characteristics and Outcomes Among Heart Failure Patients With Anemia and Renal Insufficiency With and Without Blood Transfusions (Public Discharge Data from California 2000\u20132006). The American Journal of Cardiology. 2011;107(1):69\u201373. DOI: 10.1016\/j.amjcard.2010.08.046","DOI":"10.1016\/j.amjcard.2010.08.046"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Anand IS. Anemia and Chronic Heart Failure. Journal of the American College of Cardiology. 2008;52(7):501\u201311. DOI: 10.1016\/j.jacc.2008.04.044","DOI":"10.1016\/j.jacc.2008.04.044"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Bolger AP, Bartlett FR, Penston HS, O\u2019Leary J, Pollock N, Kaprielian R et al. Intravenous Iron Alone for the Treatment of Anemia in Patients With Chronic Heart Failure. Journal of the American College of Cardiology. 2006;48(6):1225\u20137. DOI: 10.1016\/j.jacc.2006.07.015","DOI":"10.1016\/j.jacc.2006.07.015"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Graham FJ, Pellicori P, Kalra PR, Ford I, Bruzzese D, Cleland JGF. Intravenous iron in patients with heart failure and iron deficiency: an updated meta\u2010analysis. European Journal of Heart Failure. 2023;25(4):528\u201337. DOI: 10.1002\/ejhf.2810","DOI":"10.1002\/ejhf.2810"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Cleland JGF, Zhang J, Pellicori P, Dicken B, Dierckx R, Shoaib A et al. Prevalence and Outcomes of Anemia and Hematinic Deficiencies in Patients With Chronic Heart Failure. JAMA Cardiology. 2016;1(5):539. DOI: 10.1001\/jamacardio.2016.1161","DOI":"10.1001\/jamacardio.2016.1161"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Kurz K, Lanser L, Seifert M, Kocher F, P\u00f6lzl G, Weiss G. Anaemia, iron status, and gender predict the outcome in patients with chronic heart failure. ESC Heart Failure. 2020;7(4):1880\u201390. DOI: 10.1002\/ehf2.12755","DOI":"10.1002\/ehf2.12755"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Ahmed M, Shafiq A, Javaid H, Singh P, Shahbaz H, Maniya MT et al. Intravenous iron therapy for heart failure and iron deficiency: An updated meta\u2010analysis of randomized clinical trials. ESC Heart Failure. 2024;ehf2.14905. DOI: 10.1002\/ehf2.14905","DOI":"10.1002\/ehf2.14905"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal. 2021;42(36):3599\u2013726. DOI: 10.1093\/eurheartj\/ehab368","DOI":"10.1093\/eurheartj\/ehab368"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Russian Society of Cardiology (RSC) (Rsc). 2020 Clinical practice guidelines for Chronic heart failure. Russian Journal of Cardiology. 2020;25(11):4083. DOI: 10.15829\/1560-4071-2020-4083","DOI":"10.15829\/1560-4071-2020-4083"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Ponikowski P, Mentz RJ, Hernandez AF, Butler J, Khan MS, Van Veldhuisen DJ et al. Efficacy of Ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis. European Heart Journal. 2023;44(48):5077\u201391. DOI: 10.1093\/eurheartj\/ehad586","DOI":"10.1093\/eurheartj\/ehad586"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Packer M, Anker SD, Butler J, Cleland JGF, Kalra PR, Mentz RJ et al. Redefining Iron Deficiency in Patients With Chronic Heart Failure. Circulation. 2024;150(2):151\u201361. DOI: 10.1161\/CIRCULATIONAHA.124.068883","DOI":"10.1161\/CIRCULATIONAHA.124.068883"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Anker SD, Kirwan B-A, van Veldhuisen DJ, Filippatos G, Comin-Colet J, Ruschitzka F et al. Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis: Outcomes in iron-deficient heart failure patients. European Journal of Heart Failure. 2018;20(1):125\u2013 33. DOI: 10.1002\/ejhf.823","DOI":"10.1002\/ejhf.823"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Go AS, Yang J, Ackerson LM, Lepper K, Robbins S, Massie BM et al. Hemoglobin Level, Chronic Kidney Disease, and the Risks of Death and Hospitalization in Adults With Chronic Heart Failure: The Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation. 2006;113(23):2713\u201323. DOI: 10.1161\/CIRCULATIONAHA.105.577577","DOI":"10.1161\/CIRCULATIONAHA.105.577577"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Mareev V.Yu., Begrambekova Yu.L., Mareev Yu.V., Kobalava Zh.D., Karapetyan L.V., Galochkin S.A. et al. Iron deficiency in Russia heart failure patients. Observational cross-sectional multicenter study. Kardiologiia. 2022;62(5):4\u20138. DOI: 10.18087\/cardio.2022.5.n2083","DOI":"10.18087\/cardio.2022.5.n2083"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Mareev VYu, Mareev YuV, Kobalava ZhD, Begrambekova YuL, Karapetyan LV, Galochkin SA et al. In Search of Optimal Criteria for Iron Deficiency in CHF Patients. Post-hoc Analysis of the Study \u201cPrevalence of Iron Deficiency in Patients With Chronic Heart Failure in the Russian Federation (ID-CHF-RF)\u201d. Kardiologiia. 2024;64(9):16\u201327. DOI: 10.18087\/cardio.2024.9.n2732","DOI":"10.18087\/cardio.2024.9.n2732"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Grote Beverborg N, Klip IjT, Meijers WC, Voors AA, Vegter EL, van der Wal HH et al. Definition of Iron Deficiency Based on the Gold Standard of Bone Marrow Iron Staining in Heart Failure Patients. Circulation: Heart Failure. 2018;11(2):e004519. DOI: 10.1161\/CIRCHEARTFAILURE.117.004519","DOI":"10.1161\/CIRCHEARTFAILURE.117.004519"},{"key":"ref22","unstructured":"World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Available at: http:\/\/www.who.int\/vmnis\/indicators\/haemoglobin\/en\/"},{"key":"ref23","unstructured":"Belenkov Yu.N., Mareev V.Yu. Treatment of Heart Failure in the 21st Century: Achievements, Issues and Lessons of Evidence-Based Medicine. Kardiologiia. 2008;48(2):6\u201316."},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Anand IS, Gupta P. Anemia and Iron Deficiency in Heart Failure: Current Concepts and Emerging Therapies. Circulation. 2018;138(1):80\u2013 98. DOI: 10.1161\/CIRCULATIONAHA.118.030099","DOI":"10.1161\/CIRCULATIONAHA.118.030099"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Groenveld HF, Januzzi JL, Damman K, van Wijngaarden J, Hillege HL, van Veldhuisen DJ et al. Anemia and Mortality in Heart Failure Patients. Journal of the American College of Cardiology. 2008;52(10):818\u201327. DOI: 10.1016\/j.jacc.2008.04.061","DOI":"10.1016\/j.jacc.2008.04.061"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Phrommintikul A, Haas SJ, Elsik M, Krum H. Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis. The Lancet. 2007;369(9559):381\u20138. DOI: 10.1016\/S0140-6736(07)60194-9","DOI":"10.1016\/S0140-6736(07)60194-9"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Klip IjT, Comin-Colet J, Voors AA, Ponikowski P, Enjuanes C, Banasiak W et al. Iron deficiency in chronic heart failure: An international pooled analysis. American Heart Journal. 2013;165(4):575-582.e3. DOI: 10.1016\/j.ahj.2013.01.017","DOI":"10.1016\/j.ahj.2013.01.017"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Martens P, Nijst P, Verbrugge FH, Smeets K, Dupont M, Mullens W. Impact of iron deficiency on exercise capacity and outcome in heart failure with reduced, mid-range and preserved ejection fraction. Acta Cardiologica. 2018;73(2):115\u201323. DOI: 10.1080\/00015385.2017.1351239","DOI":"10.1080\/00015385.2017.1351239"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Thomas DW, Hinchliffe RF, Briggs C, Macdougall IC, Littlewood T, Cavill I et al. Guideline for the laboratory diagnosis of functional iron deficiency. British Journal of Haematology. 2013;161(5):639\u201348. DOI: 10.1111\/bjh.12311","DOI":"10.1111\/bjh.12311"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Weiss G, Goodnough LT. Anemia of chronic disease. New England Journal of Medicine. 2005;352(10):1011\u201323. DOI: 10.1056\/NEJMra041809","DOI":"10.1056\/NEJMra041809"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Nanas JN, Matsouka C, Karageorgopoulos D, Leonti A, Tsolakis E, Drakos SG et al. Etiology of anemia in patients with advanced heart failure. Journal of the American College of Cardiology. 2006;48(12):2485\u20139. DOI: 10.1016\/j.jacc.2006.08.034","DOI":"10.1016\/j.jacc.2006.08.034"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Jankowska EA, Malyszko J, Ardehali H, Koc-Zorawska E, Banasiak W, von Haehling S et al. Iron status in patients with chronic heart failure. European Heart Journal. 2013;34(11):827\u201334. DOI: 10.1093\/eurheartj\/ehs377","DOI":"10.1093\/eurheartj\/ehs377"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"IV. NKF-K\/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update 2000. American Journal of Kidney Diseases. 2001;37(1):S182\u2013238. DOI: 10.1016\/S0272-6386(01)70008-X","DOI":"10.1016\/S0272-6386(01)70008-X"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Okonko DO, Grzeslo A, Witkowski T, Mandal AKJ, Slater RM, Roughton M et al. Effect of Intravenous Iron Sucrose on Exercise Tolerance in Anemic and Nonanemic Patients With Symptomatic Chronic Heart Failure and Iron Deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. Journal of the American College of Cardiology. 2008;51(2):103\u201312. DOI: 10.1016\/j.jacc.2007.09.036","DOI":"10.1016\/j.jacc.2007.09.036"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H et al. Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency. New England Journal of Medicine. 2009;361(25):2436\u201348. DOI: 10.1056\/NEJMoa0908355","DOI":"10.1056\/NEJMoa0908355"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Ponikowski P, Kirwan B-A, Anker SD, McDonagh T, Dorobantu M, Drozdz J et al. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial. The Lancet. 2020;396(10266):1895\u2013904. DOI: 10.1016\/S0140-6736(20)32339-4","DOI":"10.1016\/S0140-6736(20)32339-4"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Kalra PR, Cleland JGF, Petrie MC, Thomson EA, Kalra PA, Squire IB et al. Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial. The Lancet. 2022;400(10369):2199\u2013209. DOI: 10.1016\/S0140-6736(22)02083-9","DOI":"10.1016\/S0140-6736(22)02083-9"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Mentz RJ, Garg J, Rockhold FW, Butler J, De Pasquale CG, Ezekowitz JA et al. Ferric Carboxymaltose in Heart Failure with Iron Deficiency. New England Journal of Medicine. 2023;389(11):975\u201386. DOI: 10.1056\/NEJMoa2304968","DOI":"10.1056\/NEJMoa2304968"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Docherty KF, Curtain JP, Anand IS, Bengtsson O, Inzucchi SE, K\u00f8ber L et al. Effect of dapagliflozin on anaemia in DAPA\u2010HF. European Journal of Heart Failure. 2021;23(4):617\u201328. DOI: 10.1002\/ejhf.2132","DOI":"10.1002\/ejhf.2132"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Packer M. Potential Interactions When Prescribing SGLT2 Inhibitors and Intravenous Iron in Combination in Heart Failure. JACC: Heart Failure. 2023;11(1):106\u201314. DOI: 10.1016\/j.jchf.2022.10.004","DOI":"10.1016\/j.jchf.2022.10.004"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Van Aelst LNL, Abraham M, Sadoune M, Lefebvre T, Manivet P, Logeart D et al. Iron status and inflammatory biomarkers in patients with acutely decompensated heart failure: early in-hospital phase and 30- day follow-up: Iron in AHF and CHF. European Journal of Heart Failure. 2017;19(8):1075\u20136. DOI: 10.1002\/ejhf.837","DOI":"10.1002\/ejhf.837"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Murphy CJ, Oudit GY. Iron-Overload Cardiomyopathy: Pathophysiology, Diagnosis, and Treatment. Journal of Cardiac Failure. 2010;16(11):888\u2013900. DOI: 10.1016\/j.cardfail.2010.05.009","DOI":"10.1016\/j.cardfail.2010.05.009"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Gammella E, Recalcati S, Rybinska I, Buratti P, Cairo G. Iron-Induced Damage in Cardiomyopathy: Oxidative-Dependent and Independent Mechanisms. Oxidative Medicine and Cellular Longevity. 2015;2015:1\u201310. DOI: 10.1155\/2015\/230182","DOI":"10.1155\/2015\/230182"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Melenovsky V, Petrak J, Mracek T, Benes J, Borlaug BA, Nuskova H et al. Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis: Iron and mitochondria in heart failure. European Journal of Heart Failure. 2017;19(4):522\u201330. DOI: 10.1002\/ejhf.640","DOI":"10.1002\/ejhf.640"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Sierpinski R, Josiak K, Suchocki T, Wojtas\u2010Polc K, Mazur G, Butrym A et al. High soluble transferrin receptor in patients with heart failure: a measure of iron deficiency and a strong predictor of mortality. European Journal of Heart Failure. 2021;23(6):919\u201332. DOI: 10.1002\/ejhf.2036","DOI":"10.1002\/ejhf.2036"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Papadopoulou C, Reinhold J, Gr\u00fcner\u2010Hegge N, Kydd A, Bhagra S, Parameshwar KJ et al. Prognostic value of three iron deficiency definitions in patients with advanced heart failure. European Journal of Heart Failure. 2023;25(11):2067\u201374. DOI: 10.1002\/ejhf.2949","DOI":"10.1002\/ejhf.2949"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Kobalava Zh.D., Lapshin A.A., Tolkacheva V.V., Galochkin S.A. Prevalence and clinical associations of iron deficiency in patients with decompensated heart failure, depending on the diagnostic criteria used for iron deficiency. Therapeutic Archive. 2022;94(7):844\u20139. DOI: 10.26442\/00403660.2022.07.201716","DOI":"10.26442\/00403660.2022.07.201716"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Grote Beverborg N, Van Der Wal HH, Klip IjT, Anker SD, Cleland J, Dickstein K et al. Differences in Clinical Profile and Outcomes of Low Iron Storage vs Defective Iron Utilization in Patients With Heart Failure: Results From the DEFINE-HF and BIOSTAT-CHF Studies. JAMA Cardiology. 2019;4(7):696. DOI: 10.1001\/jamacardio.2019.1739","DOI":"10.1001\/jamacardio.2019.1739"}],"container-title":["Kardiologiia"],"original-title":[],"link":[{"URL":"https:\/\/lib.ossn.ru\/jour\/article\/viewFile\/2786\/1758","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:16:49Z","timestamp":1793639809000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardio.elpub.ru\/jour\/article\/view\/2786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,30]]},"references-count":48,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11,30]]}},"URL":"https:\/\/doi.org\/10.18087\/cardio.2024.11.n2786","relation":{},"ISSN":["2412-5660","0022-9040"],"issn-type":[{"value":"2412-5660","type":"electronic"},{"value":"0022-9040","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,30]]}}}